Informations techniques
Exploitant
IDORSIA PHARMACEUTICALS FRANCE SAS
Présentation
QUVIVIQ 25 mg, comprimé pelliculé
plaquette(s) PVC PVDC PVC-Aluminium de 30 comprimé(s) (CIP : 34009 302 504 0 2)
QUVIVIQ 50 mg, comprimé pelliculé
plaquette(s) PVC PVDC PVC-Aluminium de 30 comprimé(s) (CIP : 34009 302 504 2 6)
eNq1mFFP2zAQx9/7KaK8N0lLGWFKi7YOtkogukK1aS/ITa7UXbDTsx3KPv2cpmxlcga4+DFx8r+L7+/fnZKcrO9yrwQUlLO+3wki3wOW8oyy274/vT5rx/7JoJUsSUl2HjsKoqDT9b00J0L0/Wo1mAFhIvh+cf4J9PuA/qDlJXy2hFQ+eU5JmgdfiFhckKJ6xktKTjPvDuSCZ32/UHJz10uERJ3F4J7jT1GQFJJwe2d3dXnT272fhJXYC1SVADwn7NYoOkcrzVQhApNDIuGW44NZOr3pxkfvoii2CkHFBARXmMKYyMUYeUkzyMyRSC7AKsj8PrsCLHOQVRCjeLhM74SVOFmS9QRWI3PSH/TqUK5lO2p3jg67h8eHvbgTHXStQuHOVpnNoz8iLG4Oer2D4+g4nGO4UiUt6aqdEaQZR1gTJi0LNeYoSe6oRFQMn5rNURyE1bNWyKgocvIQLEVhu1UEiV4G1Ehw9yHVF1yjhlSu9+wffabyPHxl1tMtQhxlXBFqyBWTDSQ5m9huxJAzCevmitrBT663XqQg3k72F2dm8I/VLKepLd80gRQIOZ2MmvHmjAwfiYApukPDN8oyfi/eHjm7JXaUfbGh5n9aZy+OY+vz9EO7qaHznCrkBYQaRVTsQ5gRm/N92aINapZ6tKcbZ25mIp6SHBqmorYlc7QlH4c4Z6Z3d6DqBaPo59NrW698VYAPV5tLozTN+n+qbAdkF5TXzmxM/PU+rw/7C+blXmw5Aio0s2QhZSHeh+GCiLbQ5wUCfZCcQn+n6bob25109nrSqdHpKPVZ3RFfXirbU/dc3993lt2+v52ZjTEkKtijDjWgnWF0dPr2ZP47yDpLe/yEJO7CbIZOIilnruYfNTMq7tcLdF3ZGWo4XM7ntOFPSqMvk7D+izNoJWH1B2fQ+g3V8/oA
UtmJart376PjtU08